Diffuse large B-cell lymphoma

M Martelli, AJM Ferreri, C Agostinelli, A Di Rocco… - Critical reviews in …, 2013 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …

Primary testicular lymphoma

CY Cheah, A Wirth, JF Seymour - Blood, The Journal of the …, 2014 - ashpublications.org
Primary testicular lymphoma (PTL) is a rare, clinically aggressive form of extranodal
lymphoma. The vast majority of cases are histologically diffuse large B-cell lymphoma, but …

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

H Tilly, MG Da Silva, U Vitolo, A Jack… - Annals of …, 2015 - annalsofoncology.org
Diffuse large B-cell lymphoma (DLBCL) constitutes 30%–58% of non-Hodgkin's lymphoma
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …

Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns

A Petrich, SI Cho, H Billett - Cancer, 2011 - Wiley Online Library
BACKGROUND: Primary cardiac lymphoma (PCL) represents a rare subset of non‐Hodgkin
lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of …

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow …

U Vitolo, JF Seymour, M Martelli… - Annals of …, 2016 - annalsofoncology.org
The aim of these guidelines is to provide practical clinical guidance and recommendations
to clinicians to manage diffuse large B-cell lymphomas (DLBCLs) that arise in extranodal …

First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an …

U Vitolo, A Chiappella, AJM Ferreri… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Primary testicular lymphoma (PTL) has poor prognosis with failures in contralateral
testis, CNS, and extranodal sites. To prevent these events, we designed an international …

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in …

V Boehme, N Schmitz, S Zeynalova… - Blood, The Journal …, 2009 - ashpublications.org
One thousand two hundred twenty-two patients treated in the Rituximab with CHOP over
age 60 years (RICOVER-60) trial were examined for central nervous system (CNS) disease …

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell …

JS Abramson, M Hellmann, JA Barnes… - Cancer, 2010 - Wiley Online Library
BACKGROUND: The outcome of patients with systemic diffuse large B‐cell lymphoma
(DLBCL) had improved over the past decade with the addition of monoclonal antibody …

How I treat patients with diffuse large B-cell lymphoma

JO Armitage - Blood, The Journal of the American Society of …, 2007 - ashpublications.org
The disease we now call diffuse large B-cell lymphoma has gone by many names in the
past. These have included reticulum cell sarcoma, 1 diffuse histiocytic lymphoma, 2 and …

[HTML][HTML] Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

G Ryan, G Martinelli, M Kuper-Hommel, R Tsang… - Annals of …, 2008 - Elsevier
Background Primary diffuse large B-cell lymphoma (DLBCL) of breast is rare. We aimed to
define clinical features, prognostic factors, patterns of failure, and treatment outcomes …